Cardiovascular Sciences Research Consortium Think Tank

Recent advances in remote monitoring technologies have empowered continuous tracking of physiologic parameters with high accuracy and granularity. However, there are important differences in the hardware, data processing, and feedback streams of individual devices which can impact the use of digital...

Full description

Saved in:
Bibliographic Details
Main Authors: Krishna Pundi, MD, Sanjeev Bhavnani, MD, Rosalyn Adigun, MD, PharmD, Jose Vicente, PhD, Rajesh Ghosh, MBA, David Albert, MD, Waqaas Al-Siddiq, DBA, Charles Benson, MD, PhD, Antoniu Fantana, PhD, Jennifer C. Goldsack, MBA, Salim F. Idriss, MD, PhD, Gregory Marcus, MD, MAS, Pamela Tenaerts, MD, MBA, Mintu P. Turakhia, MD, MAS, Jonathan Seltzer, MD, MBA
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:JACC: Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X25004843
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849398200141611008
author Krishna Pundi, MD
Sanjeev Bhavnani, MD
Rosalyn Adigun, MD, PharmD
Jose Vicente, PhD
Rajesh Ghosh, MBA
David Albert, MD
Waqaas Al-Siddiq, DBA
Charles Benson, MD, PhD
Antoniu Fantana, PhD
Jennifer C. Goldsack, MBA
Salim F. Idriss, MD, PhD
Gregory Marcus, MD, MAS
Pamela Tenaerts, MD, MBA
Mintu P. Turakhia, MD, MAS
Jonathan Seltzer, MD, MBA
author_facet Krishna Pundi, MD
Sanjeev Bhavnani, MD
Rosalyn Adigun, MD, PharmD
Jose Vicente, PhD
Rajesh Ghosh, MBA
David Albert, MD
Waqaas Al-Siddiq, DBA
Charles Benson, MD, PhD
Antoniu Fantana, PhD
Jennifer C. Goldsack, MBA
Salim F. Idriss, MD, PhD
Gregory Marcus, MD, MAS
Pamela Tenaerts, MD, MBA
Mintu P. Turakhia, MD, MAS
Jonathan Seltzer, MD, MBA
author_sort Krishna Pundi, MD
collection DOAJ
description Recent advances in remote monitoring technologies have empowered continuous tracking of physiologic parameters with high accuracy and granularity. However, there are important differences in the hardware, data processing, and feedback streams of individual devices which can impact the use of digital health technologies when evaluating safety in studies. This expert panel is the result of a think tank through a public–private partnership of the Cardiovascular Sciences Research Consortium and the U.S. Food and Drug Administration. The white paper discusses regulatory considerations for remote monitoring through digital health technologies to provide a framework for their use when evaluating safety or adverse events. It also provides practical recommendations and best practices on the implementation of these technologies into clinical trials through a scientific, technical, and operational lens. This manuscript does not constitute regulatory guidance.
format Article
id doaj-art-c8e806eed56d4fcba59f7413d76c5893
institution Kabale University
issn 2772-963X
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series JACC: Advances
spelling doaj-art-c8e806eed56d4fcba59f7413d76c58932025-08-20T03:38:40ZengElsevierJACC: Advances2772-963X2025-09-014910205910.1016/j.jacadv.2025.102059Cardiovascular Sciences Research Consortium Think TankKrishna Pundi, MD0Sanjeev Bhavnani, MD1Rosalyn Adigun, MD, PharmD2Jose Vicente, PhD3Rajesh Ghosh, MBA4David Albert, MD5Waqaas Al-Siddiq, DBA6Charles Benson, MD, PhD7Antoniu Fantana, PhD8Jennifer C. Goldsack, MBA9Salim F. Idriss, MD, PhD10Gregory Marcus, MD, MAS11Pamela Tenaerts, MD, MBA12Mintu P. Turakhia, MD, MAS13Jonathan Seltzer, MD, MBA14Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Address for correspondence: Dr Krishna Pundi, Division of Cardiovascular Medicine, Department of Medicine, Stanford University, 300 Pasteur Drive, H2146, Stanford, California 94305, USA.Department of Cardiology, Scripps Clinic, La Jolla, California, USADepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USATranslational Cures, Inc, Washington, DC, USANovartis, Cambridge, Massachusetts, USAAliveCor Inc., Mountain View, California, USABiotricity, Inc, San Francisco, California, USAEli Lilly, Indianapolis, Indiana, USAEli Lilly, Indianapolis, Indiana, USAThe Digital Medicine Society, Boston, Massachusetts, USADivision of Pediatric Electrophysiology, Duke University Medical Center, Durham, North Carolina, USADivision of Cardiology, University of California, San Francisco, San Francisco, California, USAMedable, Inc., Palo Alto, California, USADepartment of Medicine, Stanford University School of Medicine, Stanford, California, USACardiovascular Safety Research Consortium, Durham, North Carolina, USARecent advances in remote monitoring technologies have empowered continuous tracking of physiologic parameters with high accuracy and granularity. However, there are important differences in the hardware, data processing, and feedback streams of individual devices which can impact the use of digital health technologies when evaluating safety in studies. This expert panel is the result of a think tank through a public–private partnership of the Cardiovascular Sciences Research Consortium and the U.S. Food and Drug Administration. The white paper discusses regulatory considerations for remote monitoring through digital health technologies to provide a framework for their use when evaluating safety or adverse events. It also provides practical recommendations and best practices on the implementation of these technologies into clinical trials through a scientific, technical, and operational lens. This manuscript does not constitute regulatory guidance.http://www.sciencedirect.com/science/article/pii/S2772963X25004843biomarkerclinical trialdigital healthregulatory scienceremote monitoringsafety
spellingShingle Krishna Pundi, MD
Sanjeev Bhavnani, MD
Rosalyn Adigun, MD, PharmD
Jose Vicente, PhD
Rajesh Ghosh, MBA
David Albert, MD
Waqaas Al-Siddiq, DBA
Charles Benson, MD, PhD
Antoniu Fantana, PhD
Jennifer C. Goldsack, MBA
Salim F. Idriss, MD, PhD
Gregory Marcus, MD, MAS
Pamela Tenaerts, MD, MBA
Mintu P. Turakhia, MD, MAS
Jonathan Seltzer, MD, MBA
Cardiovascular Sciences Research Consortium Think Tank
JACC: Advances
biomarker
clinical trial
digital health
regulatory science
remote monitoring
safety
title Cardiovascular Sciences Research Consortium Think Tank
title_full Cardiovascular Sciences Research Consortium Think Tank
title_fullStr Cardiovascular Sciences Research Consortium Think Tank
title_full_unstemmed Cardiovascular Sciences Research Consortium Think Tank
title_short Cardiovascular Sciences Research Consortium Think Tank
title_sort cardiovascular sciences research consortium think tank
topic biomarker
clinical trial
digital health
regulatory science
remote monitoring
safety
url http://www.sciencedirect.com/science/article/pii/S2772963X25004843
work_keys_str_mv AT krishnapundimd cardiovascularsciencesresearchconsortiumthinktank
AT sanjeevbhavnanimd cardiovascularsciencesresearchconsortiumthinktank
AT rosalynadigunmdpharmd cardiovascularsciencesresearchconsortiumthinktank
AT josevicentephd cardiovascularsciencesresearchconsortiumthinktank
AT rajeshghoshmba cardiovascularsciencesresearchconsortiumthinktank
AT davidalbertmd cardiovascularsciencesresearchconsortiumthinktank
AT waqaasalsiddiqdba cardiovascularsciencesresearchconsortiumthinktank
AT charlesbensonmdphd cardiovascularsciencesresearchconsortiumthinktank
AT antoniufantanaphd cardiovascularsciencesresearchconsortiumthinktank
AT jennifercgoldsackmba cardiovascularsciencesresearchconsortiumthinktank
AT salimfidrissmdphd cardiovascularsciencesresearchconsortiumthinktank
AT gregorymarcusmdmas cardiovascularsciencesresearchconsortiumthinktank
AT pamelatenaertsmdmba cardiovascularsciencesresearchconsortiumthinktank
AT mintupturakhiamdmas cardiovascularsciencesresearchconsortiumthinktank
AT jonathanseltzermdmba cardiovascularsciencesresearchconsortiumthinktank